Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR6800 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DGKQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS33B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D22A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF446 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGFLR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPC4AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM132A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRSS8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD81 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on